Trade CNSP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
CNS Pharmaceuticals, Inc. (CNSP) is trading at US$5.78, down 2.69% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$8.52M. Over the past 52 weeks, CNSP has traded between US$1.90 and US$10.59. On Syfe you can trade CNSP with $0 commission and add it to your watchlist.
| Previous close | US$5.94 |
|---|---|
| Market cap | US$8.52M |
| 52-week range | US$1.90 – US$10.59 |
| Volume | 2.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Year: 2019
Top Midday Gainers
May 4, 5:59 PM · MT Newswires
Top Premarket Gainers
May 4, 11:52 AM · MT Newswires
CNS Pharmaceuticals, Inc. (CNSP) stock is trading at US$5.78, -2.69% from the previous close of US$5.94.
The market cap for CNS Pharmaceuticals, Inc. (CNSP) stock is approximately US$8.52M.
The 52-week high for CNS Pharmaceuticals, Inc. (CNSP) stock is US$10.59.
The 52-week low for CNS Pharmaceuticals, Inc. (CNSP) stock is US$1.90.
CNS Pharmaceuticals, Inc. (CNSP) does not currently pay a dividend.
Stay on top of CNSP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
